These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1562353)

  • 21. Effect of clofibrate on rat liver acylcarnitines.
    Kerner J; Bieber LL
    Biochem Med; 1982 Oct; 28(2):204-9. PubMed ID: 7181870
    [No Abstract]   [Full Text] [Related]  

  • 22. Impairment of hepatic glutathione S-transferase activity as a cause of reduced biliary sulfobromophthalein excretion in clofibrate-treated rats.
    Foliot A; Touchard D; Celier C
    Biochem Pharmacol; 1984 Sep; 33(18):2829-34. PubMed ID: 6477642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clofibrate induces carnitine acyltransferases in periportal and perivenous zones of rat liver and does not disturb the acinar zonation of gluconeogenesis.
    Tosh D; Alberti KG; Agius L
    Biochim Biophys Acta; 1989 Sep; 992(3):245-50. PubMed ID: 2775785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different induction of microsomal carboxylesterases, palmitoyl-CoA hydrolase and acyl-L-carnitine hydrolase in rat liver after treatment with clofibrate.
    Mentlein R; Lembke B; Vik H; Berge RK
    Biochem Pharmacol; 1986 Aug; 35(16):2727-30. PubMed ID: 2874814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The hepatocellular transport of sulfobromophthalein-glutathione by clofibrate treated, perfused rat liver.
    Sorrentino D; Weisiger RA; Bass NM; Licko V
    Lipids; 1989 May; 24(5):438-42. PubMed ID: 2755320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Action of tiadenol and clofibrate on biliary excretions of cholesterol and bile salts in rats.
    Fredj G; Clenet M; Cuchet P; Rousselet F; Rozé C
    Digestion; 1979; 19(4):228-36. PubMed ID: 478204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced uptake of carnitine by perfused rat liver following starvation.
    Kispal G; Melegh B; Alkonyi I; Sandor A
    Biochim Biophys Acta; 1987 Jan; 896(1):96-102. PubMed ID: 3024730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of clofibrate-feeding on hepatic fatty acid metabolism.
    Christiansen RZ
    Biochim Biophys Acta; 1978 Sep; 530(3):314-24. PubMed ID: 698235
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of clofibrate treatment on carnitine acyltransferases in different subcellular fractions of rat liver.
    Kahonen MT
    Biochim Biophys Acta; 1976 May; 428(3):690-701. PubMed ID: 1276175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification of clofibrate-induced carnitine acetyltransferase from rat liver mitochondria.
    Mittal B; Kurup CK
    Biochim Biophys Acta; 1980 Jul; 619(1):90-7. PubMed ID: 7417471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of clofibrate treatment on hepatic prostaglandin catabolism and action.
    Brass EP; Ruff LJ
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1034-8. PubMed ID: 2046019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection of rats by clofibrate against the hypoglycaemic and toxic effects of hypoglycin and pent-4-enoate. An ultrastructural and biochemical study.
    Van Hoof F; Hue L; Vamecq J; Sherratt HS
    Biochem J; 1985 Jul; 229(2):387-97. PubMed ID: 4038275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the effects of the hypolipidaemic agents ICI53072 and clofibrate with those of phenobarbitone on liver size, blood flow and DNA content in the rat.
    Berman JS; Hiley CR; Wilson AC
    Br J Pharmacol; 1983 Mar; 78(3):533-41. PubMed ID: 6839062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The liver carnitine pool reflects alterations in hepatic fatty acid metabolism in rats with bile duct ligation before and after biliodigestive anastomosis.
    Wächter S; Krähenbühl L; Schäfer M; Krähenbühl S
    J Hepatol; 1999 Feb; 30(2):242-8. PubMed ID: 10068103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroxisomal and mitochondrial beta-oxidation of monocarboxylyl-CoA, omega-hydroxymonocarboxylyl-CoA and dicarboxylyl-CoA esters in tissues from untreated and clofibrate-treated rats.
    Vamecq J; Draye JP
    J Biochem; 1989 Aug; 106(2):216-22. PubMed ID: 2808318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uptake, metabolism and release of carnitine and acylcarnitines in the perfused rat liver.
    Hokland BM
    Biochim Biophys Acta; 1988 Jul; 961(2):234-41. PubMed ID: 3390459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of carnitine acetyltransferase by clofibrate in rat liver.
    Mittal B; Kurup CK
    Biochem J; 1981 Jan; 194(1):249-55. PubMed ID: 6796058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of ethanol-mediated CYP2E1 induction by clofibrate and L-carnitine in rat liver.
    Tainaka H; Naito T; Murayama N; Yamazoe Y; Kato R
    Biol Pharm Bull; 1993 Dec; 16(12):1240-3. PubMed ID: 8130774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carnitine biosynthesis in hepatic peroxisomes. Demonstration of gamma-butyrobetaine hydroxylase activity.
    Paul HS; Sekas G; Adibi SA
    Eur J Biochem; 1992 Feb; 203(3):599-605. PubMed ID: 1735445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preventive effect of clofibrate on carnitine palmitoyltransferase I inhibition and mitochondrial membrane phospholipid depletion induced by galactosamine.
    Sire O; Mangeney M; Montagne J; Nordmann J
    Biochim Biophys Acta; 1986 Mar; 876(1):138-45. PubMed ID: 3947665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.